292 results on '"Heinrich, Kathrin"'
Search Results
2. Young Oncologists United (YOU) als interdisziplinäre Nachwuchsarbeitsruppe der DKG gegründet
3. Targeted RT study: results on early toxicity of targeted therapies and radiotherapy
4. Correction: Patient eligibility for trials with imaging response assessment at the time of molecular tumor board presentation
5. Patient eligibility for trials with imaging response assessment at the time of molecular tumor board presentation
6. Personalisierte Diagnostik gastrointestinaler Tumoren
7. Metabolomic profiling of upper GI malignancies in blood and tissue: a systematic review and meta-analysis
8. Primary resistance to immunotherapy in patients with a dMMR/MSI metastatic gastrointestinal cancer: who is at risk? An AGEO real-world study
9. Utility of clinical and MR imaging parameters for prediction and monitoring of response to capecitabine and temozolomide (CAPTEM) therapy in patients with liver metastases of neuroendocrine tumors
10. Implementing precision oncology for sarcoma patients: the CCCLMUmolecular tumor board experience
11. Präzisionsonkologie in Deutschland – transsektorale Vernetzung zum Wohl der Patient:innen
12. A Retrospective Analysis of Biliary Tract Cancer Patients Presented to the Molecular Tumor Board at the Comprehensive Cancer Center Munich
13. Importance of interdisciplinarity in modern oncology: results of a national intergroup survey of the Young Oncologists United (YOU)
14. Molecular characteristics of microsatellite stable early-onset colorectal cancer as predictors of prognosis and immunotherapeutic response
15. Gemcitabine and nab-paclitaxel combined with afatinib in metastatic pancreatic cancer – Results of a phase 1b clinical trial
16. Checkpoint Inhibitor Monotherapy in Potentially Trial-Eligible or Trial-Ineligible Patients With Metastatic NSCLC in the German Prospective CRISP Registry Real-World Cohort (AIO-TRK-0315)
17. Neurological Disorders and Women's Health: Contribution of Molecular Neuroimaging Techniques
18. Lessons learned: the first consecutive 1000 patients of the CCCMunichLMU Molecular Tumor Board
19. Precision Oncology in Pancreatic Cancer: Experiences and Challenges of the CCCMunichLMU Molecular Tumor Board
20. Health-related quality of life in patients with RAS wild-type metastatic colorectal cancer treated with fluorouracil and folinic acid with or without panitumumab as maintenance therapy: a prespecified secondary analysis of the PanaMa (AIO KRK 0212) trial
21. Ins Archiv hineinhören
22. Nachwuchsförderung in der AIO: die Young Medical Oncologists
23. Efficacy of immune checkpoint inhibitors in microsatellite unstable/mismatch repair-deficient advanced pancreatic adenocarcinoma: an AGEO European Cohort
24. Efficacy of FOLFIRI plus cetuximab vs FOLFIRI plus bevacizumab in 1st-line treatment of older patients with RAS wild-type metastatic colorectal cancer: an analysis of the randomised trial FIRE-3
25. First-line fluoropyrimidine plus bevacizumab followed by irinotecan-escalation versus initial fluoropyrimidine, irinotecan and bevacizumab in patients with metastatic colorectal cancer – Final survival and per-protocol analysis of the randomised XELAVIRI trial (AIO KRK 0110)
26. Case of a Patient With Pancreatic Cancer With Sporadic Microsatellite Instability Associated With a BRAF Fusion Achieving Excellent Response to Immunotherapy
27. Studien der Arbeitsgruppe Magen-Ösophagus-Tumoren der Arbeitsgemeinschaft Internistische Onkologie (AIO)
28. Nachwuchsaktivität der Jungen Onkologie
29. Erstmalige interdisziplinäre DKK-Programmplanung durch Zusammenschluss onkologischer Nachwuchsgruppen
30. Adjuvant treatment with S-1 in patients after R0-resection of adenocarcinoma of the stomach and esophagogastric junction – A multicenter phase I/II feasibility study (GMBH-STO-0114)
31. Quo vadis precision oncology?
32. Genetics and beyond: Precision Medicine Real-World Data for Patients with Cervical, Vaginal or Vulvar Cancer in a Tertiary Cancer Center
33. Understanding communication between patients and healthcare professionals regarding comprehensive biomarker testing in precision oncology: A scoping review
34. Impact of Primary Tumor Sidedness on Prognosis and Anti-EGFR Antibody Efficacy in BRAF-Mutant Metastatic Colorectal Cancer: A Pooled Analysis of AIO Studies FIRE-1, CIOX, FIRE-3, XELAVIRI, and VOLFI
35. Lokal fortgeschrittene Magen- und AEG-Tumoren: Neue Entwicklungen in der perioperativen Therapie
36. Wenn aus unheilbar heilbar wird
37. FIRE-7-Studie (AIO-KRK-0120): Virtuelle, zentrale, interdisziplinäre Tumorkonferenz zur Verbesserung der sekundären Interventionsrate in mKRK-Patienten mit RAS-Mutation unter Therapie mit FOLFOXIRI und Bevacizumab
38. Current treatment options in RAS mutant metastatic colorectal cancer patients: a meta-analysis of 14 randomized phase III trials
39. Factors That Influence Conversion to Resectability and Survival After Resection of Metastases in RAS WT Metastatic Colorectal Cancer (mCRC): Analysis of FIRE-3- AIOKRK0306
40. INNV-06. SIGNIFICANCE OF MOLECULAR DIAGNOSTICS FOR THERAPEUTIC DECISION-MAKING IN RECURRENT GLIOMA
41. Precision oncology in Germany—transsectoral networking for the benefit of patients
42. Nebenwirkungsmanagement bei Immuncheckpointinhibitoren
43. Kinderchirurgie: Basiswissen und Praxis
44. Genomanalyse maligner Tumoren: Entwicklungen und klinische Bedeutung
45. Molekulare Charakterisierung des Pankreaskarzinoms: Therapeutische Implikationen
46. 610: Targeted RT study: results on acute toxicity of targeted therapies and radiotherapy
47. OncoAlert Round Table Discussions: The Global COVID-19 Experience
48. Inclusive oncological trials and targeted treatments cannot ignore sex and gender
49. Refining first-line treatment decision in RAS wildtype (RAS-WT) metastatic colorectal cancer (mCRC) by combining clinical biomarkers: Results of the randomized phase 3 trial FIRE-3 (AIO KRK0306).
50. Predictive and prognostic value of magnesium serum level in FOLFIRI plus cetuximab or bevacizumab treated patients with stage IV colorectal cancer: results from the FIRE-3 (AIO KRK-0306) study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.